IFRX:NSD-InflaRx N.V. (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 1.44

Change

0.00 (0.00)%

Market Cap

USD 0.09B

Volume

0.21M

Analyst Target

USD 9.28
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-26 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

N/A

USD 124.65B
REGN Regeneron Pharmaceuticals Inc

N/A

USD 110.51B
MRNA Moderna Inc

N/A

USD 57.87B
BNTX BioNTech SE

N/A

USD 24.18B
ARGX argenx NV ADR

N/A

USD 23.04B
ALNY Alnylam Pharmaceuticals Inc

N/A

USD 20.29B
GMAB Genmab AS

N/A

USD 18.17B
BGNE BeiGene Ltd

N/A

USD 17.74B
RPRX Royalty Pharma Plc

N/A

USD 16.18B
BMRN Biomarin Pharmaceutical Inc

N/A

USD 15.32B

ETFs Containing IFRX

ZEO:CA BMO Equal Weight Oil & Ga.. 9.08 % 0.61 %

N/A

CAD 0.21B
XEG:CA iShares S&P/TSX Capped En.. 5.06 % 0.61 %

N/A

CAD 1.60B
WXM:CA First Asset Morningstar C.. 3.58 % 0.67 %

N/A

CAD 0.54B
XMD:CA iShares S&P/TSX Completio.. 2.52 % 0.61 %

N/A

CAD 0.24B
VSS Vanguard FTSE All-World e.. 0.35 % 0.12 %

N/A

USD 8.34B
ENY 0.00 % 0.66 %

N/A

N/A
FQC:CA 0.00 % 1.01 %

N/A

N/A
HEE:CA 0.00 % 0.84 %

N/A

N/A
SCHC Schwab International Smal.. 0.00 % 0.12 %

N/A

USD 4.15B
ZJO:CA 0.00 % 0.60 %

N/A

N/A
BREA:CA Brompton Sustainable Real.. 0.00 % 0.00 %

N/A

CAD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.66% 46% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.66% 46% F 34% F
Trailing 12 Months  
Capital Gain -65.38% 23% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -65.38% 23% F 13% F
Trailing 5 Years  
Capital Gain -96.06% 16% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -96.06% 16% F 6% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.86% 65% D 64% D
Dividend Return 6.86% 65% D 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 75.06% 37% F 21% F
Risk Adjusted Return 9.14% 68% D+ 48% F
Market Capitalization 0.09B 41% F 35% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.